Corporate Governance | Regeneron Pharmaceuticals Inc.

Date	Name	Title	Filing	Type	Shares Traded	Price	Total Held
Aug 18, 2014	Aberman Michael S VP Strategy and Investor Relat	VP Strategy and Investor Relat	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	3,843	$351.06	19,211
Feb 14, 2014	Aberman Michael S VP Strategy and Investor Relat	VP Strategy and Investor Relat	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	710	$323.30	22,390
Feb 14, 2014	Aberman Michael S VP Strategy and Investor Relat	VP Strategy and Investor Relat	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	3,142	$323.30	19,248
May 13, 2013	Aberman Michael S VP Strategy and Investor Relat	VP Strategy and Investor Relat	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	1,086	$275.97	23,114
May 13, 2013	Aberman Michael S VP Strategy and Investor Relat	VP Strategy and Investor Relat	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	5,885	$275.97	17,229
Dec 10, 2012	Aberman Michael S VP Strategy and Investor Relat	VP Strategy and Investor Relat	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	1,257	$182.68	16,743
Dec 10, 2012	Aberman Michael S VP Strategy and Investor Relat	VP Strategy and Investor Relat	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	2,875	$182.68	13,868
Nov 29, 2012	Aberman Michael S VP Strategy and Investor Relat	VP Strategy and Investor Relat	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	1,097	$182.20	17,737
Nov 29, 2012	Aberman Michael S VP Strategy and Investor Relat	VP Strategy and Investor Relat	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	3,333	$182.20	14,404
Apr 30, 2012	Aberman Michael S VP Strategy and Investor Relat	VP Strategy and Investor Relat	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	2,168	$138.31	20,332

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Investors & Media